Sorrento Therapeutics, Inc.
) was a big mover last session, as its shares rose nearly 9% on the
day. The rise came on solid volume too with far more shares
changing hands than in a normal session. This continues the uptrend
for the company since Feb 21, as the stock is now up almost 56%.
In the last 30 days, the company has not seen any estimate revision
and the Zacks Consensus Estimate also remained unchanged. However,
yesterday's price action is encouraging, so make sure to keep a
close watch on this firm in the near future.
Sorrento Therapeutics currently has a Zacks Rank #3 (Hold) while
Better-ranked medical stocks include
). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
COVIDIEN PLC (COV): Free Stock Analysis Report
NUVASIVE INC (NUVA): Free Stock Analysis Report
SORRENTO THERAP (SRNE): Get Free Report
STRYKER CORP (SYK): Free Stock Analysis Report
To read this article on Zacks.com click here.